NASDAQ:MNTA
Delisted

Momenta Pharmaceuticals Stock News

etoro logo Buy MNTA
*Your capital is at risk
$52.48
+0 (+0%)
At Close: May 27, 2022
Johnson & Johnson (NYSE: JNJ) just took a big step into the field of immunology with a $6.5 billion deal for Momenta Pharmaceuticals (NASDAQ: MNTA). On Tuesday, the giant healthcare conglomerate anno
The S&P 500 and the Nasdaq indexes hit all-time highs on Wednesday as Apple became the first publicly listed U.S. company to cross $2 trillion in market capitalization, with strong results from retail
Johnson & Johnson will buy Momenta for $6.5 billion in an all-cash deal. That's not disrupting the chart though, which has breakout potential for the stock.
WILMINGTON, Del., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Momenta Pharmaceuticals, Inc. (“Momenta”) (NASDAQ GS: MNTA) regarding possible breache
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) breached
Check out the companies making headlines in midday trading.
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Momenta Pharmaceuticals, Inc.
The S&P 500 and Nasdaq indexes hit all-time highs on Wednesday as Apple became the first publicly listed U.S. company to cross $2 trillion in market capitalization, with strong results from retailers

ROCE Insights For Momenta Pharmaceuticals

03:33pm, Wednesday, 19'th Aug 2020
During Q2, Momenta Pharmaceuticals's (NASDAQ: MNTA) reported sales totaled $6.61 million. Despite a 41.09% in earnings, the company posted a loss of $57.38 million. Momenta Pharmaceuticals collected $
Moody's Investors Service ("Moody's") affirmed the Aaa long-term ratings of Johnson & Johnson ("J&J"), as well as the Prime-1 short-term rating. The rating affirmation follows the announcement that J
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
U.S. stocks saw subdued but slightly higher trade early Wednesday, a day after the S&P 500 index scored its first record close in six months, with that all-time high marking a historic comeback for th
The S&P 500 and Nasdaq scaled record highs on Wednesday as results from retailers Target and Lowe's trounced estimates, a day after the S&P 500 completed its fastest recovery ever from a bear market.
(JNJ) said Wednesday morning it had agreed to buy the biotech firm (MNTA) in an all-cash $6.5 billion deal, acquiring rights to Momenta’s experimental drug nipocalimab, which has potential uses in
Futures pointed to slim opening gains for Wall Street's main indexes on Wednesday following results from retailers Target and Lowe's that trounced estimates, a day after the S&P 500 completed its fast
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE